Avenue Therapeutics, Inc.

We are investigating the Board of Directors of Avenue Therapeutics, Inc. ("Avenue" or the "Company") (NasdaqCM: ATXI) for possible breaches of fiduciary duty related to the sale of the company to InvaGen Pharmaceuticals, Inc. and Madison Pharmaceuticals, Inc. Under the terms of the proposed transaction, Avenue shareholders are only anticipated to receive $13.92 for each share of Avenue common stock owned.

To receive more information regarding the investigation of Avenue Therapeutics, Inc. please fill out the form below.

To start a Class Action lawsuit, please sign the Avenue Therapeutics, Inc. Retainer Agreement

This letter confirms that you have retained Monteverde & Associates PC to file a class action case and represent you as a named plaintiff in the class action against Avenue Therapeutics, Inc. . As a named plaintiff, you acknowledge that you owned shares in Avenue Therapeutics, Inc. prior to the recent takeover announcement and that you must maintain ownership in Avenue Therapeutics, Inc. throughout the litigation.

We agree to advance all expenses in the action, which means that you are not liable to pay any of the expenses of the lawsuit, whether attorneys' fees, expenses, or costs. Regardless of the result, we will never ask you to directly pay for any attorneys' fees or costs. Should we obtain a favorable result, we may ask the court to award us compensation to be paid by the defendants or as a portion of any class benefit, but, again, we will never ask you to directly pay any of the costs of this litigation.

As the client you are entitled to direct the litigation in any way you deem proper, and may at any time order us to dismiss the case or opt-out. Should you choose to do so, we will never ask you to reimburse us directly for any legal fees or expenses. During the course of this litigation, we may employ and/or work with other attorneys or law firms to prosecute your action.

We look forward to representing you in this action.

Sincerely,

Juan E. Monteverde, Esq.

Draw your signature above using your mouse.

Signed pursuant to California Civil Code Section 1633. 1, et seq. - Uniform Electronic Transactions Act as adopted by the various states and territories of the United States. 

Date of Signing: 01/18/2019